From: Prevalence and significance of serum 14–3-3η in juvenile idiopathic arthritis
Test Group | 14–3-3η+ | 95% CI for Positive Proportion | OR | 95% CI for OR | p-Value |
---|---|---|---|---|---|
PJIA RF+ | 19/39 (49%) | 32 to 65% | 3.27a | 1.10 to 10.49 | 0.029 |
7.81b | 1.52 to 78.8 | 0.008 | |||
PJIA RF- | 3/39 (8%) | 2 to 21% | 0.30a | 0.05 to 1.38 | 0.105 |
0.71b | 0.07 to 9.28 | 1.000 | |||
ERA | 2/18 (11%) | 1 to 35% | 0.44a | 0.04 to 2.62 | 0.466 |
1.06b | 0.07 to 16.3 | 1.000 | |||
OJIA | 8/36 (22%) | 10 to 39% | 2.39b | 0.41 to 25.8 | 0.465 |
PsA | 2/19 (11%) | 1 to 33% |